Publication | Open Access
What if the future of HER2‐positive breast cancer patients was written in miRNAs? An exploratory analysis from NeoALTTO study
10
Citations
17
References
2021
Year
Analyses of primary tumor tissue miRNAs hold the potential of a parsimonious tool to identify patients with differential clinical outcomes after trastuzumab based neoadjuvant therapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1